Search results
Results from the WOW.Com Content Network
Most antivirals target specific viruses, while a broad-spectrum antiviral is effective against a wide range of viruses. [2] Antiviral drugs are a class of antimicrobials, a larger group which also includes antibiotic (also termed antibacterial), antifungal and antiparasitic drugs, [3] or antiviral drugs based on monoclonal antibodies. [4]
List of Antiviral Drugs Antiviral Use Manufacturer Component Type Year approved Abacavir: HIV: ViiV Healthcare: Nucleoside analogue reverse transcriptase inhibitor (NRTI) 1998 Acyclovir (Aciclovir) Herpes Simplex, chickenpox, [2] varicella zoster virus: GSK: guanosine analogue RTI 1981 Adefovir: Hepatitis B [3] Gilead Sciences RTI 2002 , 2003 ...
The common cold, or the cold, is a viral infectious disease of the upper respiratory tract that primarily affects the respiratory mucosa of the nose, throat, sinuses, and larynx. [ 6 ] [ 8 ] Signs and symptoms may appear in as little as two days after exposure to the virus. [ 6 ]
Finding a cure for colds and the flu is tricky to say the least, but new science may help you prevent them or at least minimize those annoying symptoms.
The common cold often shares many of the symptoms associated with COVID-19 or the flu but tends to be much milder. You may have a runny nose or congestion, sneezing, sore throat, cough, slight ...
The drug was originally intended as an anti-cancer drug. [2] The anti-viral activity of vidarabine was first described by M. Privat de Garilhe and J. De Rudder in 1964. [3] It was the first nucleoside analog antiviral to be given systemically and was the first agent to be licensed for the treatment of systemic herpes virus infection in humans. [4]
High levels of T-cells from common cold coronaviruses can provide protection against COVID-19, an Imperial College London study published on Monday has found, which could inform approaches for ...
BSAs are potential candidates for treatment of emerging and re-emerging viruses, such as ebola, marburg, and SARS-CoV-2. [3] [4] Many BSAs show antiviral activity against other viruses than originally investigated (such as remdesivir and interferon alfa). Efforts in drug repurposing for SARS-CoV-2 is currently underway.